Parent-delivered early language intervention for young children with Down syndrome: assessing trial feasibility
| ISRCTN | ISRCTN63251282 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN63251282 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | ES/V016946/1 |
| Sponsor | University of Manchester |
| Funder | Economic and Social Research Council |
- Submission date
- 12/07/2023
- Registration date
- 14/07/2023
- Last edited
- 28/01/2025
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Genetic Diseases
Plain English summary of protocol
Background and study aims
Language difficulties can have a long-term impact on children’s educational outcomes and later job opportunities, their ability to take part in social activities and develop friendships, and their emotional wellbeing and mental health. Finding ways to support children’s language development is therefore important. One of the most effective ways to do this may be to provide parents with strategies, resources, and support to foster their child's language development in the home. Parents and Children Together (PACT) is a parent-delivered language teaching programme which has previously been shown to boost typically developing preschool children’s language and early literacy skills. Researchers have recently worked with families to adapt the programme for children with Down syndrome, as this group have significant language learning difficulties and need support for language development from an early age. This feasibility study aims to explore the adapted intervention (PACT-DS), measures of intervention outcomes, and trial procedures in order to inform a later, definitive trial of PACT-DS.
Who can participate?
Parents/carers of 3-6-year-old children who have Down syndrome can take part. Parents need to be able to read and speak English and families need to live within 40 miles of the University of Manchester or the University of Reading as that is where the project is taking place. Children taking part should have a minimum expressive vocabulary of 10 English words or signs, and a minimum cognitive level of 18 months which would mean for example, that the child would show interest in books, be able to attend to a picture and be able to use two hands together.
What does the study involve?
Eligible families are randomly allocated to one of two groups. The first group (PACT-DS) will be asked to attend training and provided with the PACT-DS intervention programme. They will be asked to work on the programme every day (5 days a week) for about 20 minutes a day over 30 weeks of teaching. The second group will not receive the PACT-DS programme but will instead receive three sessions of general language training throughout the 30-week delivery phase. At the end of the study, families in the control group will be given a choice of receiving PACT-DS or an alternative evidence-based reading and language intervention (RLI) which is designed specifically for school-aged children with Down syndrome. All children and parents taking part will complete assessments of children’s language as well as parent-child interactions, the home learning environment, and parent well-being before the intervention, after the 30-week intervention phase, and 6 months later.
What are the possible benefits and risks of participating?
Families taking part in the study may benefit from participation if the programme has an impact on parent-child interactions and/or the home learning environment, which may lead to gains in children’s early language skills. All families will receive a summary of their child’s assessment data at each time point which may be useful information about their child’s language abilities and progress over the course of the study. There are no perceived serious risks involved in taking part though families in the waiting control group may be disappointed not to receive the programme at the outset. To mitigate this, at recruitment all families will be fully informed about the random allocation and potential for allocation to the control group. In addition, all families in the waiting control group will receive general language training during the delivery phase (as well as their choice of PACT-DS or an alternative intervention at the end of the project).
Where is the study run from?
1. University of Manchester (UK)
2. University of Reading (UK)
When is the study starting and how long is it expected to run for?
April 2022 to April 2025
Who is funding the study?
Economic and Social Research Council (UK)
Who is the main contact?
Dr Kelly Burgoyne, Kelly.Burgoyne@manchester.ac.uk
Contact information
Principal investigator
Manchester Institute of Education
University of Manchester
Manchester
M13 9PL
United Kingdom
| 0000-0001-8765-5154 | |
| Kelly.Burgoyne@manchester.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Multicenter two-armed feasibility randomized controlled trial |
| Secondary study design | Feasibility randomized controlled trial |
| Study type | Participant information sheet |
| Scientific title | A randomised controlled feasibility trial of parent-delivered early language intervention for children with Down syndrome (PACT-DS) |
| Study acronym | PACT-DS |
| Study objectives | This is a feasibility study to assess the feasibility of a definitive randomized control trial of the PACT-DS intervention programme. The study will assess feasibility of trial procedures, adherence and acceptability of the intervention, as well as suitability of parent and child outcome measures in order to inform a full scale trial. Given this is a feasibility study, it is not appropriate to state specific hypothesis related to study outcomes. |
| Ethics approval(s) |
Approved 12/07/2023, University of Manchester Research Ethics Committee 1 (Research Governance, Ethics and Integrity; 2nd Floor Christie Building; The University of Manchester, Manchester, M13 9PL, United Kingdom; Nil known; urec1@manchester.ac.uk), ref: 2023-16509-30334 |
| Health condition(s) or problem(s) studied | Supporting early language development in children with Down syndrome |
| Intervention | Randomisation will be at the child level, stratified by site (University of Manchester/University of Reading) and by the child’s main form of communication (spoken/sign/spoken+sign) as assessed by parent report. Randomisation will be conducted by an independent randomization service provider. Children and their parents will be randomly allocated to the intervention (PACT-DS programme) group or to the waiting list control group. Families allocated to the PACT-DS group will be trained to deliver PACT-DS to their child at home in daily (5 x week) sessions of about 20-25 minutes over 30 weeks of teaching. All materials and resources needed to deliver the programme will be provided. Families in the waiting control group will be offered general training on supporting language development for children with Down syndrome. This will involve three sessions, delivered to parents as a group, over the delivery phase. In addition, on completion of the trial, they will have the option of receiving PACT-DS or an evidence-based reading intervention for children with Down syndrome (RLI). |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
The feasibility of a future definitive trial of the PACT-DS programme, assessed using: |
| Key secondary outcome measure(s) |
The outcome measures that will be evaluated within this feasibility study are listed below. The following measures are all collected at baseline (prior to randomisation) and at immediate post-test (immediately following the 30-week intervention phase) and follow-up post-test (6 months after the immediate post-test) with all participants (in both groups) with the exception of the child emergent literacy measure (assessed at 6-month follow-up only): |
| Completion date | 30/04/2025 |
Eligibility
| Participant type(s) | Carer, Other |
|---|---|
| Age group | Child |
| Lower age limit | 3 Years |
| Upper age limit | 6 Years |
| Sex | All |
| Target sample size at registration | 28 |
| Total final enrolment | 30 |
| Key inclusion criteria | 1. Child has a diagnosis of Down syndrome 2. Child aged 3-6 years at the start of the study 3. Family home postcode is within 40 miles of the University of Manchester/University of Reading 4. Parents can read and speak English 5. Child has a minimum expressive vocabulary of 10 (English) words/signs (measured via parent-completed Reading Communicative Development Inventory) 6. Child has a minimum cognitive level of 18 months (as assessed by the research team using the Mullen Scale of Early Learning) |
| Key exclusion criteria | 1. Twins will be excluded as they had higher levels of attrition in a previous study (with a different population) |
| Date of first enrolment | 01/08/2023 |
| Date of final enrolment | 30/09/2023 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centres
Oxford Road
Manchester
M13 9PR
United Kingdom
Reading
RG6 6UR
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Stored in publicly available repository |
| IPD sharing plan | The datasets generated during and/or analysed during the current study will be stored in a publicly available repository (UK Data Service https://ukdataservice.ac.uk/) |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | 07/12/2023 | 08/12/2023 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
28/01/2025: Total final enrolment added. The overall study end date was changed from 31/12/2024 to 30/04/2025.
08/12/2023: Publication reference added.
13/07/2023: Study's existence confirmed by the University of Manchester Research Ethics Committee 1.